Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study Article Swipe
Jennifer Smith
,
Loveleen Bansi‐Matharu
,
Valentina Cambiano
,
Dobromir Dimitrov
,
Anna Bershteyn
,
David van de Vijver
,
Katharine Kripke
,
Paul Revill
,
Marie‐Claude Boily
,
Gesine Meyer‐Rath
,
Isaac Taramusi
,
Jens Lundgren
,
Joep J. van Oosterhout
,
Daniel R. Kuritzkes
,
Robin Schaefer
,
Mark J. Siedner
,
Jonathan Schapiro
,
Sinéad Delany‐Moretlwe
,
Raphael J. Landovitz
,
Charles Flexner
,
Michael R. Jordan
,
François Venter
,
Mopo Radebe
,
David H. Brown Ripin
,
Sarah M. Jenkins
,
Danielle Resar
,
Carolyn Amole
,
Maryam Shahmanesh
,
Ravindra K. Gupta
,
Elliot Raizes
,
Cheryl Johnson
,
Seth Inzaule
,
Robert W. Shafer
,
Mitchell Warren
,
Sarah E. Stansfield
,
Roger Paredes
,
Andrew Phillips
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/s2352-3018(22)00365-4
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/s2352-3018(22)00365-4
Related Topics
Concepts
Pre-exposure prophylaxis
Medicine
Human immunodeficiency virus (HIV)
Dolutegravir
Emtricitabine
Virology
Men who have sex with men
Antiretroviral therapy
Viral load
Syphilis
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/s2352-3018(22)00365-4
- OA Status
- hybrid
- Cited By
- 57
- References
- 35
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4315783621
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4315783621Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/s2352-3018(22)00365-4Digital Object Identifier
- Title
-
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling studyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-01-12Full publication date if available
- Authors
-
Jennifer Smith, Loveleen Bansi‐Matharu, Valentina Cambiano, Dobromir Dimitrov, Anna Bershteyn, David van de Vijver, Katharine Kripke, Paul Revill, Marie‐Claude Boily, Gesine Meyer‐Rath, Isaac Taramusi, Jens Lundgren, Joep J. van Oosterhout, Daniel R. Kuritzkes, Robin Schaefer, Mark J. Siedner, Jonathan Schapiro, Sinéad Delany‐Moretlwe, Raphael J. Landovitz, Charles Flexner, Michael R. Jordan, François Venter, Mopo Radebe, David H. Brown Ripin, Sarah M. Jenkins, Danielle Resar, Carolyn Amole, Maryam Shahmanesh, Ravindra K. Gupta, Elliot Raizes, Cheryl Johnson, Seth Inzaule, Robert W. Shafer, Mitchell Warren, Sarah E. Stansfield, Roger Paredes, Andrew PhillipsList of authors in order
- Landing page
-
https://doi.org/10.1016/s2352-3018(22)00365-4Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/s2352-3018(22)00365-4Direct OA link when available
- Concepts
-
Pre-exposure prophylaxis, Medicine, Human immunodeficiency virus (HIV), Dolutegravir, Emtricitabine, Virology, Men who have sex with men, Antiretroviral therapy, Viral load, SyphilisTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
57Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 23, 2024: 21, 2023: 13Per-year citation counts (last 5 years)
- References (count)
-
35Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4315783621 |
|---|---|
| doi | https://doi.org/10.1016/s2352-3018(22)00365-4 |
| ids.doi | https://doi.org/10.1016/s2352-3018(22)00365-4 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/36642087 |
| ids.openalex | https://openalex.org/W4315783621 |
| fwci | 16.05545552 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | Q000188 |
| mesh[2].descriptor_ui | D015658 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | drug therapy |
| mesh[2].descriptor_name | HIV Infections |
| mesh[3].qualifier_ui | Q000453 |
| mesh[3].descriptor_ui | D015658 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | epidemiology |
| mesh[3].descriptor_name | HIV Infections |
| mesh[4].qualifier_ui | Q000517 |
| mesh[4].descriptor_ui | D015658 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | prevention & control |
| mesh[4].descriptor_name | HIV Infections |
| mesh[5].qualifier_ui | Q000379 |
| mesh[5].descriptor_ui | D065129 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | methods |
| mesh[5].descriptor_name | Pre-Exposure Prophylaxis |
| mesh[6].qualifier_ui | Q000188 |
| mesh[6].descriptor_ui | D000163 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | drug therapy |
| mesh[6].descriptor_name | Acquired Immunodeficiency Syndrome |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D003362 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Cost-Benefit Analysis |
| mesh[8].qualifier_ui | Q000494 |
| mesh[8].descriptor_ui | D019428 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | pharmacology |
| mesh[8].descriptor_name | HIV Integrase Inhibitors |
| mesh[9].qualifier_ui | Q000627 |
| mesh[9].descriptor_ui | D019428 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | therapeutic use |
| mesh[9].descriptor_name | HIV Integrase Inhibitors |
| mesh[10].qualifier_ui | Q000627 |
| mesh[10].descriptor_ui | D019426 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | therapeutic use |
| mesh[10].descriptor_name | Integrases |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D019380 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Anti-HIV Agents |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000328 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Adult |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D006801 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Humans |
| mesh[14].qualifier_ui | Q000188 |
| mesh[14].descriptor_ui | D015658 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | drug therapy |
| mesh[14].descriptor_name | HIV Infections |
| mesh[15].qualifier_ui | Q000453 |
| mesh[15].descriptor_ui | D015658 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | epidemiology |
| mesh[15].descriptor_name | HIV Infections |
| mesh[16].qualifier_ui | Q000517 |
| mesh[16].descriptor_ui | D015658 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | prevention & control |
| mesh[16].descriptor_name | HIV Infections |
| mesh[17].qualifier_ui | Q000379 |
| mesh[17].descriptor_ui | D065129 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | methods |
| mesh[17].descriptor_name | Pre-Exposure Prophylaxis |
| mesh[18].qualifier_ui | Q000188 |
| mesh[18].descriptor_ui | D000163 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | drug therapy |
| mesh[18].descriptor_name | Acquired Immunodeficiency Syndrome |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D003362 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Cost-Benefit Analysis |
| mesh[20].qualifier_ui | Q000494 |
| mesh[20].descriptor_ui | D019428 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | pharmacology |
| mesh[20].descriptor_name | HIV Integrase Inhibitors |
| mesh[21].qualifier_ui | Q000627 |
| mesh[21].descriptor_ui | D019428 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | therapeutic use |
| mesh[21].descriptor_name | HIV Integrase Inhibitors |
| mesh[22].qualifier_ui | Q000627 |
| mesh[22].descriptor_ui | D019426 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | therapeutic use |
| mesh[22].descriptor_name | Integrases |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D019380 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Anti-HIV Agents |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D000328 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Adult |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D006801 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Humans |
| mesh[26].qualifier_ui | Q000188 |
| mesh[26].descriptor_ui | D015658 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | drug therapy |
| mesh[26].descriptor_name | HIV Infections |
| mesh[27].qualifier_ui | Q000453 |
| mesh[27].descriptor_ui | D015658 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | epidemiology |
| mesh[27].descriptor_name | HIV Infections |
| mesh[28].qualifier_ui | Q000517 |
| mesh[28].descriptor_ui | D015658 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | prevention & control |
| mesh[28].descriptor_name | HIV Infections |
| mesh[29].qualifier_ui | Q000379 |
| mesh[29].descriptor_ui | D065129 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | methods |
| mesh[29].descriptor_name | Pre-Exposure Prophylaxis |
| mesh[30].qualifier_ui | Q000188 |
| mesh[30].descriptor_ui | D000163 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | drug therapy |
| mesh[30].descriptor_name | Acquired Immunodeficiency Syndrome |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D003362 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Cost-Benefit Analysis |
| mesh[32].qualifier_ui | Q000494 |
| mesh[32].descriptor_ui | D019428 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | pharmacology |
| mesh[32].descriptor_name | HIV Integrase Inhibitors |
| mesh[33].qualifier_ui | Q000627 |
| mesh[33].descriptor_ui | D019428 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | therapeutic use |
| mesh[33].descriptor_name | HIV Integrase Inhibitors |
| mesh[34].qualifier_ui | Q000627 |
| mesh[34].descriptor_ui | D019426 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | therapeutic use |
| mesh[34].descriptor_name | Integrases |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D019380 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Anti-HIV Agents |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D000328 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Adult |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D006801 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Humans |
| mesh[38].qualifier_ui | Q000188 |
| mesh[38].descriptor_ui | D015658 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | drug therapy |
| mesh[38].descriptor_name | HIV Infections |
| mesh[39].qualifier_ui | Q000453 |
| mesh[39].descriptor_ui | D015658 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | epidemiology |
| mesh[39].descriptor_name | HIV Infections |
| mesh[40].qualifier_ui | Q000517 |
| mesh[40].descriptor_ui | D015658 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | prevention & control |
| mesh[40].descriptor_name | HIV Infections |
| mesh[41].qualifier_ui | Q000379 |
| mesh[41].descriptor_ui | D065129 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | methods |
| mesh[41].descriptor_name | Pre-Exposure Prophylaxis |
| mesh[42].qualifier_ui | Q000188 |
| mesh[42].descriptor_ui | D000163 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | drug therapy |
| mesh[42].descriptor_name | Acquired Immunodeficiency Syndrome |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D003362 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Cost-Benefit Analysis |
| mesh[44].qualifier_ui | Q000494 |
| mesh[44].descriptor_ui | D019428 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | pharmacology |
| mesh[44].descriptor_name | HIV Integrase Inhibitors |
| mesh[45].qualifier_ui | Q000627 |
| mesh[45].descriptor_ui | D019428 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | therapeutic use |
| mesh[45].descriptor_name | HIV Integrase Inhibitors |
| mesh[46].qualifier_ui | Q000627 |
| mesh[46].descriptor_ui | D019426 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | therapeutic use |
| mesh[46].descriptor_name | Integrases |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D019380 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Anti-HIV Agents |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D000328 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Adult |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D006801 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Humans |
| type | article |
| title | Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study |
| biblio.issue | 4 |
| biblio.volume | 10 |
| biblio.last_page | e265 |
| biblio.first_page | e254 |
| topics[0].id | https://openalex.org/T10082 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | HIV/AIDS Research and Interventions |
| topics[1].id | https://openalex.org/T11860 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9987000226974487 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | HIV, Drug Use, Sexual Risk |
| topics[2].id | https://openalex.org/T10526 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9980999827384949 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | HIV/AIDS drug development and treatment |
| is_xpac | False |
| apc_list.value | 6300 |
| apc_list.currency | USD |
| apc_list.value_usd | 6300 |
| apc_paid.value | 6300 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 6300 |
| concepts[0].id | https://openalex.org/C2779496540 |
| concepts[0].level | 5 |
| concepts[0].score | 0.7640007138252258 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7239230 |
| concepts[0].display_name | Pre-exposure prophylaxis |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.731033444404602 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C3013748606 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5311352610588074 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q15787 |
| concepts[2].display_name | Human immunodeficiency virus (HIV) |
| concepts[3].id | https://openalex.org/C2779502633 |
| concepts[3].level | 5 |
| concepts[3].score | 0.5017085075378418 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q937224 |
| concepts[3].display_name | Dolutegravir |
| concepts[4].id | https://openalex.org/C2779778239 |
| concepts[4].level | 5 |
| concepts[4].score | 0.4501414895057678 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q422604 |
| concepts[4].display_name | Emtricitabine |
| concepts[5].id | https://openalex.org/C159047783 |
| concepts[5].level | 1 |
| concepts[5].score | 0.1841050684452057 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[5].display_name | Virology |
| concepts[6].id | https://openalex.org/C2776939746 |
| concepts[6].level | 4 |
| concepts[6].score | 0.17175006866455078 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q853451 |
| concepts[6].display_name | Men who have sex with men |
| concepts[7].id | https://openalex.org/C2993143319 |
| concepts[7].level | 4 |
| concepts[7].score | 0.16778400540351868 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q583050 |
| concepts[7].display_name | Antiretroviral therapy |
| concepts[8].id | https://openalex.org/C142462285 |
| concepts[8].level | 3 |
| concepts[8].score | 0.1454266607761383 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2528140 |
| concepts[8].display_name | Viral load |
| concepts[9].id | https://openalex.org/C2776983459 |
| concepts[9].level | 3 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q41083 |
| concepts[9].display_name | Syphilis |
| keywords[0].id | https://openalex.org/keywords/pre-exposure-prophylaxis |
| keywords[0].score | 0.7640007138252258 |
| keywords[0].display_name | Pre-exposure prophylaxis |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.731033444404602 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/human-immunodeficiency-virus |
| keywords[2].score | 0.5311352610588074 |
| keywords[2].display_name | Human immunodeficiency virus (HIV) |
| keywords[3].id | https://openalex.org/keywords/dolutegravir |
| keywords[3].score | 0.5017085075378418 |
| keywords[3].display_name | Dolutegravir |
| keywords[4].id | https://openalex.org/keywords/emtricitabine |
| keywords[4].score | 0.4501414895057678 |
| keywords[4].display_name | Emtricitabine |
| keywords[5].id | https://openalex.org/keywords/virology |
| keywords[5].score | 0.1841050684452057 |
| keywords[5].display_name | Virology |
| keywords[6].id | https://openalex.org/keywords/men-who-have-sex-with-men |
| keywords[6].score | 0.17175006866455078 |
| keywords[6].display_name | Men who have sex with men |
| keywords[7].id | https://openalex.org/keywords/antiretroviral-therapy |
| keywords[7].score | 0.16778400540351868 |
| keywords[7].display_name | Antiretroviral therapy |
| keywords[8].id | https://openalex.org/keywords/viral-load |
| keywords[8].score | 0.1454266607761383 |
| keywords[8].display_name | Viral load |
| language | en |
| locations[0].id | doi:10.1016/s2352-3018(22)00365-4 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2531945440 |
| locations[0].source.issn | 2352-3018, 2405-4704 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2352-3018 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | The Lancet HIV |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | The Lancet HIV |
| locations[0].landing_page_url | https://doi.org/10.1016/s2352-3018(22)00365-4 |
| locations[1].id | pmid:36642087 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | The lancet. HIV |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/36642087 |
| locations[2].id | pmh:oai:eprints.whiterose.ac.uk:195910 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306400854 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | White Rose Research Online (University of Leeds, The University of Sheffield, University of York) |
| locations[2].source.host_organization | https://openalex.org/I2800616092 |
| locations[2].source.host_organization_name | White Rose University Consortium |
| locations[2].source.host_organization_lineage | https://openalex.org/I2800616092 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | acceptedVersion |
| locations[2].raw_type | PeerReviewed |
| locations[2].license_id | |
| locations[2].is_accepted | True |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | |
| locations[3].id | pmh:oai:researchonline.lshtm.ac.uk:4668560 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306402527 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | LSHTM Research Online (London School of Hygiene and Tropical Medicine) |
| locations[3].source.host_organization | https://openalex.org/I4210089966 |
| locations[3].source.host_organization_name | London School of Hygiene & Tropical Medicine |
| locations[3].source.host_organization_lineage | https://openalex.org/I4210089966 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | acceptedVersion |
| locations[3].raw_type | NonPeerReviewed |
| locations[3].license_id | |
| locations[3].is_accepted | True |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://researchonline.lshtm.ac.uk/view/creators/lsh1603327.html>; |
| locations[4].id | pmh:oai:pubmedcentral.nih.gov:10065903 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S2764455111 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | PubMed Central |
| locations[4].source.host_organization | https://openalex.org/I1299303238 |
| locations[4].source.host_organization_name | National Institutes of Health |
| locations[4].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[4].license | cc-by |
| locations[4].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10065903/pdf/nihms-1877277.pdf |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Text |
| locations[4].license_id | https://openalex.org/licenses/cc-by |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Lancet HIV |
| locations[4].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10065903 |
| locations[5].id | pmh:oai:spiral.imperial.ac.uk:10044/1/101981 |
| locations[5].is_oa | True |
| locations[5].source.id | https://openalex.org/S4306401396 |
| locations[5].source.issn | |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | Spiral (Imperial College London) |
| locations[5].source.host_organization | https://openalex.org/I47508984 |
| locations[5].source.host_organization_name | Imperial College London |
| locations[5].source.host_organization_lineage | https://openalex.org/I47508984 |
| locations[5].license | other-oa |
| locations[5].pdf_url | |
| locations[5].version | submittedVersion |
| locations[5].raw_type | Journal Article |
| locations[5].license_id | https://openalex.org/licenses/other-oa |
| locations[5].is_accepted | False |
| locations[5].is_published | False |
| locations[5].raw_source_name | e265 |
| locations[5].landing_page_url | http://hdl.handle.net/10044/1/101981 |
| locations[6].id | pmh:eur:oai:pure.eur.nl:publications/0ddb9996-8777-47ca-b5bb-83b46ba5d006 |
| locations[6].is_oa | True |
| locations[6].source.id | https://openalex.org/S4306401843 |
| locations[6].source.issn | |
| locations[6].source.type | repository |
| locations[6].source.is_oa | False |
| locations[6].source.issn_l | |
| locations[6].source.is_core | False |
| locations[6].source.is_in_doaj | False |
| locations[6].source.display_name | Data Archiving and Networked Services (DANS) |
| locations[6].source.host_organization | https://openalex.org/I1322597698 |
| locations[6].source.host_organization_name | Royal Netherlands Academy of Arts and Sciences |
| locations[6].source.host_organization_lineage | https://openalex.org/I1322597698 |
| locations[6].license | cc-by |
| locations[6].pdf_url | |
| locations[6].version | submittedVersion |
| locations[6].raw_type | info:eu-repo/semantics/article |
| locations[6].license_id | https://openalex.org/licenses/cc-by |
| locations[6].is_accepted | False |
| locations[6].is_published | False |
| locations[6].raw_source_name | The Lancet HIV, 10(4), e254 - e265. Elsevier Ltd. |
| locations[6].landing_page_url | https://pure.eur.nl/en/publications/0ddb9996-8777-47ca-b5bb-83b46ba5d006 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5100773542 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8809-8553 |
| authorships[0].author.display_name | Jennifer Smith |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I45129253 |
| authorships[0].affiliations[0].raw_affiliation_string | Joint first authors Institute for Global Health, University College London, London, UK |
| authorships[0].institutions[0].id | https://openalex.org/I45129253 |
| authorships[0].institutions[0].ror | https://ror.org/02jx3x895 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I45129253 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | University College London |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jennifer Smith |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Joint first authors Institute for Global Health, University College London, London, UK |
| authorships[1].author.id | https://openalex.org/A5042459578 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0233-7622 |
| authorships[1].author.display_name | Loveleen Bansi‐Matharu |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I45129253 |
| authorships[1].affiliations[0].raw_affiliation_string | Joint first authors Institute for Global Health, University College London, London, UK |
| authorships[1].institutions[0].id | https://openalex.org/I45129253 |
| authorships[1].institutions[0].ror | https://ror.org/02jx3x895 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I45129253 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | University College London |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Loveleen Bansi-Matharu |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Joint first authors Institute for Global Health, University College London, London, UK |
| authorships[2].author.id | https://openalex.org/A5016768242 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0700-105X |
| authorships[2].author.display_name | Valentina Cambiano |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I45129253 |
| authorships[2].affiliations[0].raw_affiliation_string | Joint first authors Institute for Global Health, University College London, London, UK |
| authorships[2].institutions[0].id | https://openalex.org/I45129253 |
| authorships[2].institutions[0].ror | https://ror.org/02jx3x895 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I45129253 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | University College London |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Valentina Cambiano |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Joint first authors Institute for Global Health, University College London, London, UK |
| authorships[3].author.id | https://openalex.org/A5058788810 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2842-5436 |
| authorships[3].author.display_name | Dobromir Dimitrov |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Dobromir Dimitrov |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5058436429 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-6604-7093 |
| authorships[4].author.display_name | Anna Bershteyn |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Anna Bershteyn |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5084575089 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5877-8526 |
| authorships[5].author.display_name | David van de Vijver |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | David van de Vijver |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5009144891 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-8228-4577 |
| authorships[6].author.display_name | Katharine Kripke |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Katharine Kripke |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5017336802 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8632-0600 |
| authorships[7].author.display_name | Paul Revill |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Paul Revill |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5032456643 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-3919-006X |
| authorships[8].author.display_name | Marie‐Claude Boily |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Marie-Claude Boily |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5031952967 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-0439-381X |
| authorships[9].author.display_name | Gesine Meyer‐Rath |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Gesine Meyer-Rath |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5030096621 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-5871-2874 |
| authorships[10].author.display_name | Isaac Taramusi |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Isaac Taramusi |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5080120008 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-8901-7850 |
| authorships[11].author.display_name | Jens Lundgren |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Jens D Lundgren |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5010630492 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-3441-0804 |
| authorships[12].author.display_name | Joep J. van Oosterhout |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Joep J van Oosterhout |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5058715015 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-6196-5883 |
| authorships[13].author.display_name | Daniel R. Kuritzkes |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Daniel Kuritzkes |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5068806732 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-4733-4692 |
| authorships[14].author.display_name | Robin Schaefer |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Robin Schaefer |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5003051495 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-3506-842X |
| authorships[15].author.display_name | Mark J. Siedner |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Mark J Siedner |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5110224117 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Jonathan Schapiro |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Jonathan Schapiro |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5077847014 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-0376-1019 |
| authorships[17].author.display_name | Sinéad Delany‐Moretlwe |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Sinead Delany-Moretlwe |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5045910681 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-1442-714X |
| authorships[18].author.display_name | Raphael J. Landovitz |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Raphael J Landovitz |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5017420608 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-4495-5349 |
| authorships[19].author.display_name | Charles Flexner |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Charles Flexner |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5052083685 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-2177-0405 |
| authorships[20].author.display_name | Michael R. Jordan |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Michael Jordan |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5017874022 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-4157-732X |
| authorships[21].author.display_name | François Venter |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Francois Venter |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5008098889 |
| authorships[22].author.orcid | |
| authorships[22].author.display_name | Mopo Radebe |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Mopo Radebe |
| authorships[22].is_corresponding | False |
| authorships[23].author.id | https://openalex.org/A5070627756 |
| authorships[23].author.orcid | |
| authorships[23].author.display_name | David H. Brown Ripin |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | David Ripin |
| authorships[23].is_corresponding | False |
| authorships[24].author.id | https://openalex.org/A5031595426 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-4157-8066 |
| authorships[24].author.display_name | Sarah M. Jenkins |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Sarah Jenkins |
| authorships[24].is_corresponding | False |
| authorships[25].author.id | https://openalex.org/A5057978178 |
| authorships[25].author.orcid | https://orcid.org/0009-0006-3865-9523 |
| authorships[25].author.display_name | Danielle Resar |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Danielle Resar |
| authorships[25].is_corresponding | False |
| authorships[26].author.id | https://openalex.org/A5005647566 |
| authorships[26].author.orcid | |
| authorships[26].author.display_name | Carolyn Amole |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Carolyn Amole |
| authorships[26].is_corresponding | False |
| authorships[27].author.id | https://openalex.org/A5043916447 |
| authorships[27].author.orcid | https://orcid.org/0000-0001-7129-8535 |
| authorships[27].author.display_name | Maryam Shahmanesh |
| authorships[27].countries | ES |
| authorships[27].affiliations[0].raw_affiliation_string | Shafer MD); AVAC, New York, NY, USA (M Warren BA); |
| authorships[27].affiliations[1].institution_ids | https://openalex.org/I4210086361, https://openalex.org/I4210090054 |
| authorships[27].affiliations[1].raw_affiliation_string | Department of Infectious Diseases, Irsi Caixa Institut de Recerca de la SIDA, Barcelona, Spain |
| authorships[27].institutions[0].id | https://openalex.org/I4210086361 |
| authorships[27].institutions[0].ror | https://ror.org/001synm23 |
| authorships[27].institutions[0].type | nonprofit |
| authorships[27].institutions[0].lineage | https://openalex.org/I4210086361, https://openalex.org/I4387153040 |
| authorships[27].institutions[0].country_code | ES |
| authorships[27].institutions[0].display_name | IrsiCaixa |
| authorships[27].institutions[1].id | https://openalex.org/I4210090054 |
| authorships[27].institutions[1].ror | https://ror.org/00c77q313 |
| authorships[27].institutions[1].type | facility |
| authorships[27].institutions[1].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210090054, https://openalex.org/I4387152914 |
| authorships[27].institutions[1].country_code | ES |
| authorships[27].institutions[1].display_name | Red de Investigación en Sida |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Maryam Shahmanesh |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | Department of Infectious Diseases, Irsi Caixa Institut de Recerca de la SIDA, Barcelona, Spain, Shafer MD); AVAC, New York, NY, USA (M Warren BA); |
| authorships[28].author.id | https://openalex.org/A5036869978 |
| authorships[28].author.orcid | https://orcid.org/0000-0001-9751-1808 |
| authorships[28].author.display_name | Ravindra K. Gupta |
| authorships[28].countries | ES |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I4210086361, https://openalex.org/I4210090054 |
| authorships[28].affiliations[0].raw_affiliation_string | Department of Infectious Diseases, Irsi Caixa Institut de Recerca de la SIDA, Barcelona, Spain |
| authorships[28].affiliations[1].raw_affiliation_string | Shafer MD); AVAC, New York, NY, USA (M Warren BA); |
| authorships[28].institutions[0].id | https://openalex.org/I4210086361 |
| authorships[28].institutions[0].ror | https://ror.org/001synm23 |
| authorships[28].institutions[0].type | nonprofit |
| authorships[28].institutions[0].lineage | https://openalex.org/I4210086361, https://openalex.org/I4387153040 |
| authorships[28].institutions[0].country_code | ES |
| authorships[28].institutions[0].display_name | IrsiCaixa |
| authorships[28].institutions[1].id | https://openalex.org/I4210090054 |
| authorships[28].institutions[1].ror | https://ror.org/00c77q313 |
| authorships[28].institutions[1].type | facility |
| authorships[28].institutions[1].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210090054, https://openalex.org/I4387152914 |
| authorships[28].institutions[1].country_code | ES |
| authorships[28].institutions[1].display_name | Red de Investigación en Sida |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Ravindra K Gupta |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | Department of Infectious Diseases, Irsi Caixa Institut de Recerca de la SIDA, Barcelona, Spain, Shafer MD); AVAC, New York, NY, USA (M Warren BA); |
| authorships[29].author.id | https://openalex.org/A5026793185 |
| authorships[29].author.orcid | https://orcid.org/0000-0001-5121-877X |
| authorships[29].author.display_name | Elliot Raizes |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | Elliot Raizes |
| authorships[29].is_corresponding | False |
| authorships[30].author.id | https://openalex.org/A5003587385 |
| authorships[30].author.orcid | https://orcid.org/0000-0001-5499-5523 |
| authorships[30].author.display_name | Cheryl Johnson |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | Cheryl Johnson |
| authorships[30].is_corresponding | False |
| authorships[31].author.id | https://openalex.org/A5058207584 |
| authorships[31].author.orcid | |
| authorships[31].author.display_name | Seth Inzaule |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | Seth Inzaule |
| authorships[31].is_corresponding | False |
| authorships[32].author.id | https://openalex.org/A5066628402 |
| authorships[32].author.orcid | https://orcid.org/0000-0003-2513-2643 |
| authorships[32].author.display_name | Robert W. Shafer |
| authorships[32].author_position | middle |
| authorships[32].raw_author_name | Robert Shafer |
| authorships[32].is_corresponding | False |
| authorships[33].author.id | https://openalex.org/A5038298636 |
| authorships[33].author.orcid | https://orcid.org/0000-0003-3626-7156 |
| authorships[33].author.display_name | Mitchell Warren |
| authorships[33].author_position | middle |
| authorships[33].raw_author_name | Mitchell Warren |
| authorships[33].is_corresponding | False |
| authorships[34].author.id | https://openalex.org/A5012783085 |
| authorships[34].author.orcid | https://orcid.org/0000-0003-3251-8501 |
| authorships[34].author.display_name | Sarah E. Stansfield |
| authorships[34].author_position | middle |
| authorships[34].raw_author_name | Sarah Stansfield |
| authorships[34].is_corresponding | False |
| authorships[35].author.id | https://openalex.org/A5091097962 |
| authorships[35].author.orcid | https://orcid.org/0000-0002-6553-691X |
| authorships[35].author.display_name | Roger Paredes |
| authorships[35].author_position | middle |
| authorships[35].raw_author_name | Roger Paredes |
| authorships[35].is_corresponding | False |
| authorships[36].author.id | https://openalex.org/A5004174170 |
| authorships[36].author.orcid | https://orcid.org/0000-0003-2384-4807 |
| authorships[36].author.display_name | Andrew Phillips |
| authorships[36].countries | DK, ZW |
| authorships[36].affiliations[0].institution_ids | https://openalex.org/I4210155141 |
| authorships[36].affiliations[0].raw_affiliation_string | Bershteyn PhD); National AIDS Council, Harare, Zimbabwe (I Taramusi MPH); |
| authorships[36].affiliations[1].institution_ids | https://openalex.org/I124055696, https://openalex.org/I2802709434 |
| authorships[36].affiliations[1].raw_affiliation_string | Department of Clinical Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark |
| authorships[36].institutions[0].id | https://openalex.org/I2802709434 |
| authorships[36].institutions[0].ror | https://ror.org/03mchdq19 |
| authorships[36].institutions[0].type | healthcare |
| authorships[36].institutions[0].lineage | https://openalex.org/I2802567020, https://openalex.org/I2802709434, https://openalex.org/I4210145385 |
| authorships[36].institutions[0].country_code | DK |
| authorships[36].institutions[0].display_name | Rigshospitalet |
| authorships[36].institutions[1].id | https://openalex.org/I124055696 |
| authorships[36].institutions[1].ror | https://ror.org/035b05819 |
| authorships[36].institutions[1].type | education |
| authorships[36].institutions[1].lineage | https://openalex.org/I124055696 |
| authorships[36].institutions[1].country_code | DK |
| authorships[36].institutions[1].display_name | University of Copenhagen |
| authorships[36].institutions[2].id | https://openalex.org/I4210155141 |
| authorships[36].institutions[2].ror | https://ror.org/05ee4t010 |
| authorships[36].institutions[2].type | government |
| authorships[36].institutions[2].lineage | https://openalex.org/I4210155141 |
| authorships[36].institutions[2].country_code | ZW |
| authorships[36].institutions[2].display_name | National AIDS Council |
| authorships[36].author_position | last |
| authorships[36].raw_author_name | Andrew N Phillips |
| authorships[36].is_corresponding | True |
| authorships[36].raw_affiliation_strings | Bershteyn PhD); National AIDS Council, Harare, Zimbabwe (I Taramusi MPH);, Department of Clinical Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/s2352-3018(22)00365-4 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10082 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | HIV/AIDS Research and Interventions |
| related_works | https://openalex.org/W2996250544, https://openalex.org/W2480205263, https://openalex.org/W4200628507, https://openalex.org/W4231963197, https://openalex.org/W4313237195, https://openalex.org/W2909170247, https://openalex.org/W2899935160, https://openalex.org/W2084039221, https://openalex.org/W2149708245, https://openalex.org/W4285752796 |
| cited_by_count | 57 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 23 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 21 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 13 |
| locations_count | 7 |
| best_oa_location.id | doi:10.1016/s2352-3018(22)00365-4 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2531945440 |
| best_oa_location.source.issn | 2352-3018, 2405-4704 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 2352-3018 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | The Lancet HIV |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | The Lancet HIV |
| best_oa_location.landing_page_url | https://doi.org/10.1016/s2352-3018(22)00365-4 |
| primary_location.id | doi:10.1016/s2352-3018(22)00365-4 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2531945440 |
| primary_location.source.issn | 2352-3018, 2405-4704 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2352-3018 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | The Lancet HIV |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | The Lancet HIV |
| primary_location.landing_page_url | https://doi.org/10.1016/s2352-3018(22)00365-4 |
| publication_date | 2023-01-12 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W3036686930, https://openalex.org/W2767990008, https://openalex.org/W2922043465, https://openalex.org/W2804603775, https://openalex.org/W3190424399, https://openalex.org/W4226116413, https://openalex.org/W2147475182, https://openalex.org/W3030616052, https://openalex.org/W4221037082, https://openalex.org/W3137354410, https://openalex.org/W4225003302, https://openalex.org/W2902025352, https://openalex.org/W2160271190, https://openalex.org/W2943444687, https://openalex.org/W3155554351, https://openalex.org/W4213411987, https://openalex.org/W3167680445, https://openalex.org/W2971168736, https://openalex.org/W2954620310, https://openalex.org/W4225307087, https://openalex.org/W3193532577, https://openalex.org/W3135120250, https://openalex.org/W3004456128, https://openalex.org/W4308374271, https://openalex.org/W2470199959, https://openalex.org/W1991541076, https://openalex.org/W3183487031, https://openalex.org/W3127280839, https://openalex.org/W3170630453, https://openalex.org/W4225272808, https://openalex.org/W2286756681, https://openalex.org/W4229456555, https://openalex.org/W4229018258, https://openalex.org/W4243241014, https://openalex.org/W4226267447 |
| referenced_works_count | 35 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 99 |
| corresponding_author_ids | https://openalex.org/A5004174170 |
| countries_distinct_count | 4 |
| institutions_distinct_count | 37 |
| corresponding_institution_ids | https://openalex.org/I124055696, https://openalex.org/I2802709434, https://openalex.org/I4210155141 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8399999737739563 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.99256658 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |